Browsing by Keyword "Fosfomicina"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
Publication Análisis Epidemiológico de las infecciones urinarias y la exposición a Fosfomicina durante el embarazo en madres de niños con y sin defectos congénitos: Distribución por años y por comunidades autónomas(Instituto de Salud Carlos III (ISCIII). Instituto de Investigación de Enfermedades Raras (IIER), 2011-12) García-Benítez, María Regla; Real, María Montserrat; Fernández, Paloma; Bermejo-Sanchez, Eva; Martínez-Frías, María LuisaThe objective of this study was to epidemiologically analyze urinary tract infections (UTI) suffered by pregnant women, and the prenatal exposure to Fosfomycin. To accomplish this objective, data from the Spanish Collaborative Study of Congenital Malformations (ECEMC) were analyzed for the period 1978-2009. A total of 40,060 newborn infants with congenital defects, and a similar number of healthy controls were registered. The proportions of mothers of cases and controls who suffered UTI during the first trimester were 2.69% and 2.56%, respectively. These figures go up to 9.94% and 8.86% when considering UTI at any time during pregnancy. The proportions of mothers who were treated with fosfomycin during the first trimester of pregnancy were 0.67% and 0.69%, respectively for cases and controls, and those figures go up to 2.69% y 2.54% when considering exposures at any time during pregnancy. Use of fosfomycin at any time during pregnancy has progressively increased with time. When studying the geographical distribution of the frequency some differences regarding UTI and use of fosfomycin were detected. The increase in use of fosfomycin has caused a decrease of the use of other antibiotics, and these trends are also observed in several autonomous regions in Spain. The use of fosfomycin during pregnancy seems to be safe, and suffering an UTI is quite common during pregnancy and somehow dangerous for the progress of gestation. It is important to underline that the percentage of mothers without treatment was between 20 and 35%. Therefore, it is advisable to treat UTI as soon as possible, in order to avoid complications both for the mother and fetus.Publication Jornada de encuentro del Programa de Doctorado en Ciencias Biomédicas y Salud pública IMIENS-UNED-ISCIII(2023-06-22) Instituto de Salud Carlos IIIEl Programa de Doctorado en Ciencia Biomédicas y Salud Pública IMIENS-UNED-ISCIII se inició en el curso 2020-2021 y cuenta ya con un total de 105 doctorandos. El objetivo de esta jornada es intercambiar experiencias entre los doctorandos y doctorandas, analizar resultados de los trabajos en torno a las tesis y debatir propuestas de mejora del Programa de Doctorado. La jornada se celebró el 22 de junio de 2023 en el Centro Nacional de Microbiología del ISCIII de manera presencial y también on-line. La conferencia inaugural corrió a cargo de Inmaculada Casas Flecha: "Potencial Pandémico de los Virus Respiratorios: desde la Gripe al SARS-CoV-2 y desde el SARS-CoV-2 a la Gripe", seguida de otra presentación de Ángel de Juanas Oliva (Directo de la Escuela Internacional de Doctorado de la UNED) y Cristina Bojo Canales (Área de Coordinación de la Investigación del ISCIII) con el título: "Salidas profesionales después de la finalización de la tesis doctoral". 18 doctorandos expusieron comunicaciones breves y la jornada terminó con una mesa redonda sobre el tema "Debate sobre formas de desarrollo tesis doctoral. ISCIII. UNED".